Work

Digoxin as an inhibitor of global hypoxia inducible factor-1α (HIF1α) expression and downstream targets in breast cancer: Dig-HIF1 pharmacodynamic trial.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.tps1144

Authors: Aditya Bardia, Cesar Augusto Santa-Maria, Lisa K. Jacobs, Ashley Cimino-Mathews, Peng Huang, Stuart Russell, Melissa Camp, Mehran Habibi, Julie R. Lange, Stacie Jeter, Penny Powers, Shannon Slater, Edward Gabrielson, Michael Anthony Carducci, Gregg Semenza, Vered Stearns

Institutions: Harvard University, Massachusetts General Hospital, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Cancer, Hypoxia, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2958239483

Cites:

Cited by: 4

Related to: 10